SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-000477
Accepted
2024-02-16 00:15:09
Documents
1
Effectiveness Date
2024-02-15
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 608
  Complete submission text file 9999999995-24-000477.txt   1871
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: EFFECT | Act: 33 | File No.: 333-264987 | Film No.: 24645671
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)